Bleakley Financial Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,367	Closed	-$246K	–	868
2024 Q4	$246K	Sell	6,367 -664	-9%	-$25.6K	0.01%	875
2024 Q3	$316K	Buy	+7,031	New	+$316K	0.01%	746
2023 Q4	–	Sell	-10,411	Closed	-$174K	–	970
2023 Q3	$174K	Buy	+10,411	New	+$174K	0.01%	811